CLINICAL TRIAL CHALLENGES FOR HEART FAILURE INTERVENTIONS: EVOLVING EMERGING MEDICAL THERAPIES AND ADAPTING TO A NEW NORMAL POST PANDEMIC

Tuesday, February 28, 2023

11:50 AM – 1:00 PM ET

Moderator(s)

William T. Abraham, MD

Professor of Medicine
The Ohio State University
Columbus, Ohio, United States

Disclosure(s): Boehringer Ingelheim: Committee/Planning Member (Ongoing); Impulse Dynamics: Consultant/Advisory Board (Ongoing); V-WAVE Medical: Salary (Ongoing), Stock-privately held company (Ongoing); Zoll Respicardia: Advisor (Ongoing)
Ileana L. Pina, MD, MPH (she/her/hers)

Professor of Medicine
Thomas Jefferson University
Cleveland hts, Ohio, United States

Disclosure(s): boerhinger ingelheim: Advisory Committee/Board Member (Ongoing)
Meir Shinnar, MD, PhD

Medical Officer
FDA
Teaneck, New Jersey, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

William T. Abraham, MD: Boehringer Ingelheim: Committee/Planning Member (Ongoing); Impulse Dynamics: Consultant/Advisory Board (Ongoing); V-WAVE Medical: Salary (Ongoing), Stock-privately held company (Ongoing); Zoll Respicardia: Advisor (Ongoing)

Ileana L. Pina, MD, MPH: boerhinger ingelheim: Advisory Committee/Board Member (Ongoing)

Meir Shinnar, MD, PhD: No financial relationships to disclose